Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Amatsigroup S.A.S

Amatsigroup, as a CDMO (Contract Development and Manufacturing Organization), provides preclinical and clinical stage services for the development of human and veterinary drugs. Amatsigroup, founded in 2010, was formed through the merger of four companies (Avogadro, Amatsi, DBI, Avepharm) bringing complementary expertise. As of 2014, Amatsigroup began to expand internationally with the acquisition of its subsidiaries SEPS Pharma in Belgium and Amatsigroup Inc. (Indiana, USA). Its international expansion continued in 2015 with the acquisition of Pierre Fabre's pharmaceutical analysis laboratory in Saint-Augustin, France. With more than 240 highly qualified staff and a diversified clientele of 300 international pharmaceutical groups and biotech companies, Amatsigroup is the leading provider of services for the development of veterinary and human pharmaceutical products. Amatsigroup contributed to the development and registration of more than 30 drugs for use in human health clinical trials and more than 20 in animal health. Amatsigroup provides its customers with a broad array of international services in five core business areas: > Bioservices: PK, ADME, residues, tolerance studies and preclinical and clinical bioanalysis. > Pharmaceutical analysis solutions: analytical method development and validation, stability studies, quality control on API and drug products. > Formulation development and manufacturing: galenic development, non-sterile and sterile trial and clinical batch manufacturing. > Clinical trial supply ¦ Packaging and logistics: GMP storage, packaging, labeling, QP release and worldwide distribution. > Biologicals: bioprocesses, biomanufacturing and control. *


Period Start 2010-01-01 merged
  Group Eurofins (Group)
Products Industry contract manufacturing (drugs)
  Industry 2 drug development services
Region Region Toulouse
  Country France
  Street 2 bis avenue de Gascogne
  City 31470 Fontenilles
    Address record changed: 2024-01-05
Basic data Employees D: 101 to 500 (2017-07-10)
  Currency EUR
  Annual sales 60,000,000 (revenues, planned (2017) 2017-12-31)
    * Document for »About Section«: 
Record changed: 2024-02-12


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Eurofins (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top